Published in J Lipid Res on August 01, 1988
Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones. Gut (1990) 1.07
Isolation of an acidic protein from cholesterol gallstones, which inhibits the precipitation of calcium carbonate in vitro. J Clin Invest (1989) 0.86
Cyclosporin A reduces canalicular membrane fluidity and regulates transporter function in rats. Biochem J (2001) 0.81
Phospholipid alterations in hepatocyte membranes and transporter protein changes in cholestatic rat model. Dig Dis Sci (2001) 0.78
Transcytotic vesicle fusion is reduced in cholestatic rats: redistribution of phospholipids in the canalicular membrane. Dig Dis Sci (1999) 0.77
Modifying hepatic phospholipid synthesis associates with biliary phospholipid secretion rate in a transporter-independent manner in rats: relation to canalicular membrane fluidity. Dig Dis Sci (2001) 0.76
Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function. Biochem J (2001) 0.76
Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones. Gut (1993) 0.75
Biliary tract cancers. N Engl J Med (1999) 6.36
Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology (1980) 3.57
Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology (1998) 2.75
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology (1989) 2.39
Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res (2000) 2.38
Current concepts. Primary sclerosing cholangitis. N Engl J Med (1984) 2.35
The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol (2000) 2.25
Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 2.06
Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver. Gastroenterology (1989) 1.89
Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology (1982) 1.88
Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest (1987) 1.88
Monooctanoin, a dissolution agent for retained cholesterol bile duct stones: physical properties and clinical application. Gastroenterology (1980) 1.84
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78
Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology (1996) 1.76
Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. J Hepatol (2000) 1.70
Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology (1990) 1.69
Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol (1998) 1.68
Recent advances in the isolation of liver cells. Hepatology (1994) 1.63
Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. Ann Surg (1993) 1.63
Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption. N Engl J Med (1974) 1.58
Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations. N Engl J Med (1985) 1.57
Development and characterization of polarized primary cultures of rat intrahepatic bile duct epithelial cells. Lab Invest (1996) 1.56
Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol (2001) 1.52
Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51
Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology (1983) 1.49
Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol (1997) 1.47
Secretin stimulates exocytosis in isolated bile duct epithelial cells by a cyclic AMP-mediated mechanism. J Biol Chem (1992) 1.47
A revised natural history model for primary sclerosing cholangitis. Mayo Clin Proc (2000) 1.45
Molecular and functional heterogeneity of cholangiocytes from rat liver after bile duct ligation. Am J Physiol (1997) 1.44
Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. Gastroenterology (1986) 1.43
Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. Gut (1975) 1.41
Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest (2001) 1.40
Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology (2001) 1.40
A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation. Kidney Int (2007) 1.38
Cryptosporidium parvum activates nuclear factor kappaB in biliary epithelia preventing epithelial cell apoptosis. Gastroenterology (2001) 1.36
Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol (1985) 1.34
Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology (1985) 1.34
The water channel aquaporin-8 is mainly intracellular in rat hepatocytes, and its plasma membrane insertion is stimulated by cyclic AMP. J Biol Chem (2001) 1.32
The isolated perfused rat liver: conceptual and practical considerations. Hepatology (1986) 1.31
Secretin promotes osmotic water transport in rat cholangiocytes by increasing aquaporin-1 water channels in plasma membrane. Evidence for a secretin-induced vesicular translocation of aquaporin-1. J Biol Chem (1997) 1.30
Coordinate secretion of acid hydrolases in rat bile. J Clin Invest (1979) 1.30
Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. J Clin Invest (1997) 1.29
Calpain activity increases in hepatocytes following addition of ATP. Demonstration by a novel fluorescent approach. J Biol Chem (1993) 1.28
Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol (1994) 1.27
Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol (1988) 1.26
Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells. Gastroenterology (2000) 1.26
Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism. Am J Physiol Gastrointest Liver Physiol (2007) 1.26
Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile. Science (1984) 1.26
Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology (1999) 1.26
Polarized expression and function of P2Y ATP receptors in rat bile duct epithelia. Am J Physiol Gastrointest Liver Physiol (2001) 1.24
Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide. Cancer Res (2001) 1.24
Cholelitholysis using methyl tertiary butyl ether. Gastroenterology (1985) 1.24
Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology (1983) 1.20
Effect of primary bile acid ingestion on bile acid metabolism and biliary lipid secretion in gallstone patients. Gastroenterology (1975) 1.16
Validity and sensitivity of an intravenous bile acid tolerance test in patients with liver disease. N Engl J Med (1975) 1.16
Secretin induces the apical insertion of aquaporin-1 water channels in rat cholangiocytes. Am J Physiol (1999) 1.15
Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc (1993) 1.15
Interaction of metronidazole with nucleic acids in vitro. Mol Pharmacol (1977) 1.15
Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am J Physiol (1999) 1.14
Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology (1999) 1.14
Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. Gastroenterology (1989) 1.13
Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease. Gastroenterology (1976) 1.11
Regulation of bicarbonate-dependent ductular bile secretion assessed by lumenal micropuncture of isolated rodent intrahepatic bile ducts. Proc Natl Acad Sci U S A (1993) 1.11
Determinants of fasting and postprandial serum bile acid levels in healthy man. Am J Dig Dis (1978) 1.08
Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology (1992) 1.08
Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line. Hepatology (1997) 1.06
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology (1999) 1.05
Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes. Am J Physiol (1998) 1.05
Effect of deoxycholic acid ingestion on bile acid metabolism and biliary lipid secretion in normal subjects. Gastroenterology (1977) 1.04
Novel tool for the study of cholecystokinin-stimulated pancreatic enzyme secretion. J Clin Invest (1989) 1.04
Anatomy of the human biliary system studied by quantitative computer-aided three-dimensional imaging techniques. Hepatology (1998) 1.03
Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis. Arch Intern Med (1989) 1.03
Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology (1988) 1.02
Quantitative assessment of the rat intrahepatic biliary system by three-dimensional reconstruction. Am J Pathol (2001) 1.02
Perfused rat intrahepatic bile ducts secrete and absorb water, solute, and ions. Gastroenterology (2000) 1.00
Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1983) 1.00
Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport properties. Proc Natl Acad Sci U S A (2000) 0.99
Primary sclerosing cholangitis and celiac disease. A novel association. Ann Intern Med (1988) 0.99
Cholangiocytes express the aquaporin CHIP and transport water via a channel-mediated mechanism. Proc Natl Acad Sci U S A (1994) 0.99
Development of an intravenous bile acid tolerance test. Plasma disappearance of cholylglycine in health. N Engl J Med (1975) 0.98
Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. J Biol Chem (1987) 0.96
Isolation and characterization of rat cholangiocyte vesicles enriched in apical or basolateral plasma membrane domains. Biochemistry (1995) 0.95
Biliary copper excretion by hepatocyte lysosomes in the rat. Major excretory pathway in experimental copper overload. J Clin Invest (1989) 0.95
The metabolic bone disease of primary sclerosing cholangitis. Hepatology (1991) 0.95
Proteins in bile: how they get there and what they do. Am J Physiol (1984) 0.95
Effect of chloroquine on the form and function of hepatocyte lysosomes. Morphologic modifications and physiologic alterations related to the biliary excretion of lipids and proteins. Gastroenterology (1983) 0.95
Triton WR-1339, a lysosomotropic compound, is excreted into bile and alters the biliary excretion of lysosomal enzymes and lipids. Hepatology (1982) 0.94
Cholangiocarcinomas express Fas ligand and disable the Fas receptor. Hepatology (1999) 0.94
Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis. Hepatology (1986) 0.94
Molecular studies of ceruloplasmin deficiency in Wilson's disease. J Clin Invest (1987) 0.94
Biliary and renal excretion, hepatic metabolism, and hepatic subcellular distribution of metronidazole in the rat. Biochem Pharmacol (1978) 0.94
Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology (1985) 0.93
Hepatic processing of cholecystokinin peptides. I. Structural specificity and mechanism of hepatic extraction. Am J Physiol (1986) 0.93
Morphologic demonstration of receptor-mediated endocytosis of epidermal growth factor by isolated bile duct epithelial cells. Gastroenterology (1990) 0.93
Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci (1987) 0.91
Biliary excretion of iron from hepatocyte lysosomes in the rat. A major excretory pathway in experimental iron overload. J Clin Invest (1986) 0.91
Apolipoproteins of high, low, and very low density lipoproteins in human bile. J Lipid Res (1983) 0.91
Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis. AJR Am J Roentgenol (1985) 0.90
Gallbladder disease in patients with primary sclerosing cholangitis. AJR Am J Roentgenol (1988) 0.90